Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

NCT00623103 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

583

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease Dementia

Interventions

DRUG: Rivastigmine capsule
DRUG: Rivastigmine transdermal patch

Sponsor

Novartis